Accu-Chek Guide and Accu-Chek Performa blood glucose meters 14 November 2019 Product defect correction – risk of delayed therapy due to potential battery issues Consumers and healthcare professionals are advised that Roche Diabetes Care Australia, in consultation with the Therapeutic Goods Administration (TGA), is undertaking a product defect correction for Accu-Chek Guide and Accu-Chek Performa blood glucose meters. Accu-Chek Guide and Accu-Chek Performa blood glucose meters are used by people with diabetes to monitor their blood glucose (also known as blood sugar) levels. These meters are supplied individually and also in a meter kit. Please visit www.accu-chek.com.au for more information. The TGA Safety Advisory can be found at: https://www.tga.gov.au/alert/accu-chek-guide-and-accu-chek-performa-blood-glucose-meters
News 19 January 2026 National Diabetes Summit to convene at Federal Parliament Australia’s response to one of its most significant health challenges will come into sharp focus at Diabetes Australia’s National Diabetes... Continue Reading
News 16 January 2026 Wegovy to be listed on PBS The Pharmaceutical Benefits Advisory Committee (PBAC) has recommended Wegovy (semaglutide) be subsidised through the Pharmaceutical Benefits Scheme (PBS) for adults with established cardiovascular disease and obesity. Diabetes Australia’s Group CEO... Continue Reading
Blog 15 January 2026 Five signs it’s time to book a diabetes telehealth appointment Accessing telehealth can be useful if you are newly diagnosed, you feel unwell, or if you are navigating a life transition. Continue Reading
